Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 01/23 07:52:02 pm
100.929 EUR   -1.53%
01/18DJBayer Joins Jobs Parade -- WSJ
01/18DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Upda..
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Bayer Joins Jobs Parade -- WSJ

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/18/2017 | 08:49am CET
By Jacob Bunge in Chicago and Christopher Alessi in Frankfurt 

Bayer AG has pledged to add U.S. jobs and investment after meeting with President-elect Donald Trump, the latest in a string of public displays from companies looking to head off criticism from the incoming administration about job losses.

The German chemical conglomerate, which is seeking regulatory approval for its planned $57 billion purchase of biotech seed maker Monsanto Co., said Tuesday it would step up research investments and create "several thousand" new high-tech positions in the U.S. after completing the deal targeted to close by the end of the year.

The pledge came hours after General Motors Co. separately confirmed a plan to invest a further $1 billion in its U.S. manufacturing operations, and Hyundai Motor Co. outlined a new $3.1 billion investment in existing U.S. manufacturing plants. Also on Tuesday, Wal-Mart Stores Inc. touted its previous plans to add about 10,000 U.S. jobs this year, following online retailer Amazon.com Inc.'s announcement last week of an additional 100,000 full-time U.S. jobs, mostly through expansion plans already in the works.

According to Trump transition team spokesman Sean Spicer, Bayer's decision was the result of "the president-elect's focus on creating a better business climate here in the United States."

Mr. Spicer's comments, made to reporters on a conference call Tuesday, could leave Bayer and Monsanto little room to deviate from the employment commitment.

Companies large and smaller are pondering their prospects under Mr. Trump, who is set for inauguration Friday, and has wasted little time since his November election spotlighting companies he sees shirking their responsibility to the U.S. market and workers.

Following a campaign that emphasized job creation and domestic business expansion, Mr. Trump vowed to bring back manufacturing positions to the U.S., and since his election has castigated companies for shifting operations abroad while praising others for domestic expansion plans.

That has presented companies with the choice to strike a deal with Mr. Trump's team -- as Carrier Corp. did in November, keeping about 1,000 jobs in Indiana in return for new government incentives -- or reverse plans to shift some manufacturing abroad like Ford Motor Co. did recently. Others are opting to lie low, hoping to stay clear of the incoming president's Twitter feed. Wal-Mart's jobs plan, which derives from previously planned store expansions and openings and new e-commerce services, suggests that even the country's largest private employer feels the need to tout American job growth.

Concern over whether Bayer's planned takeover of Monsanto could hurt U.S. farmers' competitiveness was one factor behind a meeting in New York last week between Mr. Trump and Bayer Chief Executive Werner Baumann and Monsanto CEO Hugh Grant.

Some farmers and state officials on a committee created to advise the Trump campaign on farm policy this month called on the president-elect to block tie-ups between some of the agricultural industry's biggest players, saying competition will slacken and prices for seeds and crop sprays will rise.

Besides Bayer's Monsanto deal, which would create the world's No. 1 supplier by sales of both seeds and pesticides, Dow Chemical Co. and DuPont Co. are pursuing a merger that would create another agricultural giant, while China National Chemical Corp. plans to buy Swiss pesticide maker Syngenta AG.

Bayer said Tuesday it aims to invest over the next six years about $16 billion to research new crop seeds and pesticides, with half that spending planned for the U.S., while adding several thousand new high-tech positions in the U.S.

Mr. Spicer went further, telling reporters Tuesday that Bayer's Mr. Baumann pledged to keep all of Monsanto's more than 9,000 U.S. jobs in the country and to create at least 3,000 new U.S. high-tech jobs.

A Bayer spokesman declined to elaborate on specific numbers.

While Bayer has said its deal for Monsanto isn't based on cutting costs from the combined businesses, the German company has targeted about $1.5 billion in cost savings from the deal. On a September conference call with employees, Mr. Baumann acknowledged that some layoffs could be inevitable due to overlapping jobs.

Bayer's Tuesday commitment on R&D spending works out to a total of about $2.7 billion a year, which isn't far from what the companies already spend. Monsanto spent slightly more than $1.5 billion on research and development efforts in each of the past two years, while Bayer spent about $1 billion in agricultural R&D in 2014 and $1.17 billion in 2015.

"The United States is a global leader in agriculture, and the combination of Bayer-Monsanto will underscore that role and ensure the United States retains a pre-eminent position as the anchor of the industry," Bayer and Monsanto said in a joint statement following Mr. Spicer's comments.

While Mr. Trump's critiques of megamergers like AT&T Inc.'s planned takeover of Time Warner Inc. have fueled investor concern that he could take aim at other big deals, antitrust lawyers said that questions of lost jobs -- and pledges to keep them -- typically don't factor into the nitty-gritty of deal reviews.

"This kind of environment on the outside is, to the [antitrust] agencies, very unhealthy," said Bill Kovacic, professor of competition law at George Washington University and former chairman of the Federal Trade Commission. "It creates the impression that the competition agencies are a direct extension of the political process."

Write to Christopher Alessi at christopher.alessi@wsj.com and Jacob Bunge at jacob.bunge@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
01/18DJBayer Joins Jobs Parade -- WSJ
01/18DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Update
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- Update
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says
01/12 BAYER : Regorafenib from Bayer Granted Priority Review in the U.S. for Second-Li..
01/12 Bayer says had productive meeting with Trump over Monsanto deal
01/12 BAYER : CEOs of Monsanto and Bayer meet with Trump, press case for merger
01/11DJBAYER : Monsanto CEOs Pitch Deal to Trump
01/10 BAYER : MILITARY $6,894 Federal Contract Awarded to Bayer HealthCare
01/09 BAYER : Volker Koch-Achelpöhler to head Bayer’s EU Liaison Office in Bruss..
More news
Sector news : Pharmaceuticals - NEC
01/20 European shares ease ahead of Trump inauguration
01/20 Bristol-Myers shares fall on lung cancer timeline setback
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/19 Davos CEOs 'go local' on supply chain in Trump era
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/18 Xbiotech Has A Great Upside Potential With Only Limited Downside After Reveal..
01/18 Bayer Has Little Upside Left
01/18 Vet med industry now dominated by four firms; further mergers unlikely
01/18 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q4 2016 Update
01/17 Bayer, Monsanto confirm spending, jobs plans after meeting Trump
Advertisement
Financials (€)
Sales 2016 46 746 M
EBIT 2016 8 695 M
Net income 2016 4 762 M
Debt 2016 15 852 M
Yield 2016 2,62%
P/E ratio 2016 17,67
P/E ratio 2017 15,78
EV / Sales 2016 2,15x
EV / Sales 2017 1,99x
Capitalization 84 762 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 109 €
Spread / Average Target 6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG3.40%90 687
JOHNSON & JOHNSON-0.92%310 549
ROCHE HOLDING LTD.0.39%200 499
PFIZER INC.-2.19%192 792
NOVARTIS AG-4.32%185 152
MERCK & CO., INC.6.22%172 404
More Results